Can ACC Serve as a Biomarker for Cancer Diagnosis or Prognosis?
Due to its elevated expression in various cancers, ACC1 has potential as a biomarker for cancer diagnosis and prognosis. Studies have shown that high levels of ACC1 correlate with poor prognosis in cancers such as breast cancer, prostate cancer, and non-small cell lung cancer. Measuring ACC1 levels could therefore aid in the early detection and assessment of cancer progression.
